EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes after SynCardia ® temporary total artificial heart implantation: A 20‐year single‐center experience in 196 patients

Artyom Razumov iD, Melchior Burri, Armin Zittermann, Darko Radakovic iD, Volker Lauenroth, Sebastian V Rojas, Henrik Fox iD, René Schramm, Jan Gummert, Marcus-André Deutsch, Michiel Morshuis

Artificial Organs · 2025

DOI: 10.1111/aor.14860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Artyom Razumov und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germa…. Hauptthemen laut MEDLINE: Heart, Artificial, Heart Failure, Heart-Assist Devices. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The SynCardia® temporary total artificial heart (TAH) serves as a mechanical circulatory support device for patients suffering from irreversible biventricular failure.

Methods

This retrospective study analyzed 196 consecutive patients who underwent TAH implantation at our center from 2001 to 2021. We assessed survival rates and all‐cause mortality during TAH support, including survival post‐heart transplantation.

Results

The median age of patients was 55 years, with 88% being male. The primary diagnoses included cardiomyopathy (43.9%), acute myocardial infarction (26.5%), and postcardiotomy heart failure (15.5%). At implantation, 87.2% of patients were classified as INTERMACS Profile 1. The median duration of support was 96 days (IQR: 23–227). Survival rates at 1, 6, and 12 months were 72%, 41%, and 34%, respectively. Postoperative rethoracotomy was necessary in 44.4% of patients; 39.3% experienced neurological events and 24.6% developed gastrointestinal bleeding. Overall, 64.8% of patients died while on support, primarily due to multiple organ failure (55.9%). Factors such as older age, higher bilirubin levels, postcardiotomy and specific underlying diagnoses were independent predictors of mortality during TAH support. On a positive note, 35.2% of patients underwent successful heart transplants, with 1‐, 5‐, and 10‐year posttransplant survival rates of 65%, 58%, and 51%, respectively.

Conclusions

While high mortality rates persist among patients with biventricular failure, the SynCardia® TAH offers a viable interim solution for critically ill patients, particularly those who can be successfully bridged to heart transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart, ArtificialHeart FailureHeart-Assist DevicesHumansMaleFemaleMiddle AgedRetrospective StudiesAdultHeart TransplantationTreatment OutcomeAgedSurvival RatePostoperative Complications

Stichwörter der Autor:innen

biventricular supportheart failuretotal artificial heart

Autor:innen und Institutionen

  • Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany.
  • Department of Cardiovascular Surgery, German Heart Centre Munich, Technical University of Munich, Munich, Germany.

ORCID-Profile: Artyom Razumov, Darko Radakovic, Henrik Fox

Zitieren

APA

Razumov, A., Burri, M., Zittermann, A., Radakovic, D., Lauenroth, V., Rojas, S. V., Fox, H., Schramm, R., Gummert, J., Deutsch, M. A., & Morshuis, M. (2025). Outcomes after SynCardia ® temporary total artificial heart implantation: A 20‐year single‐center experience in 196 patients. Artificial Organs. https://doi.org/10.1111/aor.14860

Vancouver

Razumov A, Burri M, Zittermann A, Radakovic D, Lauenroth V, Rojas SV, et al. Outcomes after SynCardia ® temporary total artificial heart implantation: A 20‐year single‐center experience in 196 patients. Artificial Organs. 2025. doi:10.1111/aor.14860

BibTeX
@article{Razumov2025,
  author = {Razumov, Artyom and Burri, Melchior and Zittermann, Armin and Radakovic, Darko and Lauenroth, Volker and Rojas, Sebastian V and Fox, Henrik and Schramm, René and Gummert, Jan and Deutsch, Marcus-André and Morshuis, Michiel},
  title = {Outcomes after SynCardia ® temporary total artificial heart implantation: A 20‐year single‐center experience in 196 patients},
  journal = {Artificial Organs},
  year = {2025},
  doi = {10.1111/aor.14860}
}
Kostenlos starten →